128 related articles for article (PubMed ID: 38039759)
21. Oncogene-mediated nuclear accumulation of lactate promotes epigenetic alterations to induce cancer cell proliferation.
Bandopadhyay S; Kamal IM; Padmanaban E; Ghosh DD; Chakrabarti S; Roy SS
J Cell Biochem; 2023 Apr; 124(4):495-519. PubMed ID: 36999756
[TBL] [Abstract][Full Text] [Related]
22. Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
Kaur P; Nagar S; Bhagwat M; Uddin M; Zhu Y; Vancurova I; Vancura A
PLoS One; 2021; 16(11):e0260400. PubMed ID: 34807950
[TBL] [Abstract][Full Text] [Related]
23. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
[TBL] [Abstract][Full Text] [Related]
24. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation.
Zheng X; Boyer L; Jin M; Mertens J; Kim Y; Ma L; Ma L; Hamm M; Gage FH; Hunter T
Elife; 2016 Jun; 5():. PubMed ID: 27282387
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
26. Nonhormonal therapy for endometriosis based on energy metabolism regulation.
Kobayashi H; Shigetomi H; Imanaka S
Reprod Fertil; 2021 Dec; 2(4):C42-C57. PubMed ID: 35118411
[TBL] [Abstract][Full Text] [Related]
27. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.
Zhang J; Gao Q; Zhou Y; Dier U; Hempel N; Hochwald SN
Oncogene; 2016 Apr; 35(15):1926-42. PubMed ID: 26119934
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
29. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
30. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
[TBL] [Abstract][Full Text] [Related]
31. Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
Chen L; Cheng X; Tu W; Qi Z; Li H; Liu F; Yang Y; Zhang Z; Wang Z
Cell Oncol (Dordr); 2019 Oct; 42(5):679-690. PubMed ID: 31325096
[TBL] [Abstract][Full Text] [Related]
32. TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer.
Chen M; Sheng XJ; Qin YY; Zhu S; Wu QX; Jia L; Meng N; He YT; Yan GR
Theranostics; 2019; 9(3):676-690. PubMed ID: 30809301
[TBL] [Abstract][Full Text] [Related]
33. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
Li R; Li P; Wang J; Liu J
Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
[TBL] [Abstract][Full Text] [Related]
34. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
35. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing.
Zhou Y; Guo Y; Ran M; Shan W; Granchi C; Giovannetti E; Minutolo F; Peters GJ; Tam KY
Cancer Lett; 2023 Nov; 577():216425. PubMed ID: 37805163
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
[TBL] [Abstract][Full Text] [Related]
37. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
Wu H; Wang X; Wu T; Yang S
Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
Zhang M; Liu Q; Zhang M; Cao C; Liu X; Zhang M; Li G; Xu C; Zhang X
J Nanobiotechnology; 2020 Nov; 18(1):161. PubMed ID: 33160373
[TBL] [Abstract][Full Text] [Related]
39. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
40. NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway.
Zhang Z; Luan Q; Hao W; Cui Y; Li Y; Li X
J Cancer; 2023; 14(13):2562-2573. PubMed ID: 37670970
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]